Humacyte Company
Humacyte is a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at a commercial scale to improve the lives of patients and transform the practice of medicine.
Investors
Connections from
Founded Date:
01.01.2004
Technology:
Specific disorder-related
Funding Status:
Private investment in public equity(PIPE)
Total Funding:
$400 000 000
Employee Number:
101-250
Headquarters:
United States
Last Funding Date:
17.02.2021
Investors Number:
9
Last Funding Type:
Reverse Merger
Estimated Revenue:
$10-50 Mn
Industry:
Longevity